Elisa Giusti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisa Giusti has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Andre M. M. Sousa
Waisman Center, University of Wisconsin-Madison, Madison, USA
1 shared publication - Anita Bhattacharyya
University of Wisconsin-Madison
1 shared publication - Carlos J. Wang
Waisman Center, University of Wisconsin–Madison, Madison, WI, USA
1 shared publication - Daifeng Wang
Waisman Center, University of Wisconsin-Madison, Madison, USA
1 shared publication Danielle K. Schmidt
Waisman Center, University of Wisconsin–Madison, Madison, WI, USA
1 shared publication- Jie Sheng
Department of Biostatistics and Medical Informatics, University of Wisconsin; Madison, WI 53705, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 23 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eaea1549
Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Down syndrome is a genetic condition that causes intellectual disability and is characterized by early-onset delays in motor, cognitive, and language development. The molecular mechanisms underlying these neurodevelopmental impairments remain poorly understood. We used single-nucleus multiomic sequencing to simultaneously profile gene expression and chromatin accessibility in the Down syndrome prefrontal cortex during early postnatal development, a critical period for synaptogenesis, neural maturation, and developmental neuroimmune interactions. Our findings reveal widespread dysregulation of chromatin accessibility and gene expression, with deficits spanning metabolic and synaptic pathways, oligodendrocyte lineage progression, and a pronounced neuroinflammatory signature. We present a molecular atlas of Down syndrome neuropathology at a critical stage of brain development, highlighting convergent neurodevelopmental and neurodegenerative pathways and informing potential targeted therapies for Down syndrome–associated neuroinflammation.
- 23 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eaea1549
Top Cited PapersMolecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Down syndrome is a genetic condition that causes intellectual disability and is characterized by early-onset delays in motor, cognitive, and language development. The molecular mechanisms underlying these neurodevelopmental impairments remain poorly understood. We used single-nucleus multiomic sequencing to simultaneously profile gene expression and chromatin accessibility in the Down syndrome prefrontal cortex during early postnatal development, a critical period for synaptogenesis, neural maturation, and developmental neuroimmune interactions. Our findings reveal widespread dysregulation of chromatin accessibility and gene expression, with deficits spanning metabolic and synaptic pathways, oligodendrocyte lineage progression, and a pronounced neuroinflammatory signature. We present a molecular atlas of Down syndrome neuropathology at a critical stage of brain development, highlighting convergent neurodevelopmental and neurodegenerative pathways and informing potential targeted therapies for Down syndrome–associated neuroinflammation.